KCRS23 Leadership Committee

TONI CHOUEIRI, MD
Director, Lank Center for Genitourinary Oncology

HANS HAMMERS, MD, PhD
Professor of Internal Medicine, Division of Hematology-Oncology

RANA MCKAY, MD
Associate Professor of Medicine

THOMAS POWLES, MBBS, MRCP, MD
Director, Barts Cancer Centre

BRYAN LEWIS
President

SUSAN POTEAT
Medical Science Liaison

STEVEN CHANG, MD, MS
Brigham and Women’s Hospital
Associate Surgeon

DEEPAK KILARI, MD
Medical College of Wisconsin
Associate Professor

JOSHUA LANG, MD, MS
University of Wisconsin School of Medicine
Associate Professor

CHUNG-HAN LEE, MD, PhD
Memorial Sloan Kettering Cancer Center
Assistant Attending Physician

RANA MCKAY, MD
Associate Professor of Medicine

SUMANTA PAL, MD
City of Hope Comprehensive Cancer Center
Professor, Department of Medical Oncology & Therapeutics Research

BRIAN SHUCH, MD
University of California, Los Angeles
Associate Professor of Urology

WENXIN (Vincent) XU, MD
Dana-Farber Cancer Institute
Instructor of Medicine

ARI HAKIMI, MD, PhD
Memorial Sloan Kettering Cancer Center
Associate Professor

ERIC JONASCH, MD
Professor, Department of Genitourinary Medical Oncology

SRINIVAS VISWANATHAN, MD, PhD
Assistant Professor of Medicine, Harvard Medical School

QING ZHANG, PhD
Associate Professor

DAVID BRAUN, MD, PhD
Assistant Professor of Medicine

NAZLI DIZMAN, MD
MD Anderson Cancer Center
Internal Medicine Resident

GIL MORGAN, MD
Medical Oncologist

PAVLOS MSAOUEL, MD, PhD
Assistant Professor, Department of Genitourinary Medical Oncology

FABIO SCHUTZ, MD
Oncologista Clinico

MICHAEL SERZAN, MD
Dana-Farber Cancer Institute
Medical Oncologist

QING ZHANG, PhD
UT Southwestern
Associate Professor

TIAN ZHANG, MD
UT Southwestern
Associate Professor

ADRIAN HAYES
KidneyCAN
Communications
Mentorship: Challenges and Opportunities

HANS HAMMERS, MD, PhD
UT Southwestern Medical Center
Professor of Internal Medicine, Division of Hematology-Oncology

THOMAS POWLES, MBBS, MRCP, MD
Barts Cancer Centre
Lead for Solid Tumour Research
panelists

LAURENCE ALBIGES, MD, PhD
Urology Committee Chairman

TONI CHOUEIRI, MD
Dana-Farber Cancer Institute
Director, Lank Center for Genitourinary Oncology

NAZLI DIZMAN, MD
Yale School of Medicine
Internal Medicine Resident

RANA MCKAY, MD
Associate Professor of Medicine

SUMANTA PAL, MD
City of Hope Comprehensive Cancer Center
Professor, Department of Medical Oncology & Therapeutics Research

RENEE MARIA SALIBY, MD
Dana-Farber Cancer Institute
Postdoctoral Research Fellow
session 1
Modulating Tumor Microenvironment in Kidney Cancer

ERIC JONASCH, MD
Professor, Department of Genitourinary Medical Oncology

ARI HAKIMI, MD, PhD
Memorial Sloan Kettering Cancer Center
Associate Professor
speakers

RUHEE DERE, PhD
Baylor College of Medicine
Assistant Professor

ELEONORA DONDOSSOLA, PhD
MD Anderson Cancer Center
Assistant Professor

HARTLAND JACKSON, PhD
Samuel Lunenfeld Research Institute
Investigator, Assistant Professor

W. KIMRYN RATHMELL, MD, PhD
Vanderbilt University Medical Center
Director, Division of Hematology & Oncology
session 2
Biology of Non-Clear Cell Subtypes
MODERATORS / SPEAKERS

ELIZABETH HENSKE, MD
Brigham and Women’s Hospital
Professor of Medicine

SRINIVAS VISWANATHAN, MD, PhD
Dana-Farber Cancer Institute
Assistant Professor of Medicine, Harvard Medical School

KAUSHAL ASRANI, MBBS, PhD
John Hopkins University
Research Associate

JUNG WOOK PARK, PhD
Duke Cancer Institute
Rollie Assistant Professorship of Correlative Pathology
session 3
Trials in Progress: Moving the Needle
MODERATORS

NAOMI HAAS, MD
Penn Medicine
Clinical Leader of Kidney Cancer Program

ROBERT MOTZER, MD
Memorial Sloan Kettering Cancer Center
Jack and Dorothy Byrne Chair in Clinical Oncology
SPEAKERS

KATY BECKERMANN, MD, PhD
Vanderbilt University Medical Center
Assistant Professor

TONI CHOUEIRI, MD
Director, Lank Center for Genitourinary Oncology

ERIC JONASCH, MD
Professor, Department of Genitourinary Medical Oncology

DAVID MCDERMOTT, MD
Beth Israel Deaconess Medical Center
Chief, Division of Medical Oncology

RANA MCKAY, MD
Associate Professor of Medicine

NEIL J SHAH, MBBS
Memorial Sloan Kettering Cancer Center
Assistant Attending
special session 4
Breaking Barriers to Trial Enrollment

MICHAEL B ATKINS, MD
Georgetown Lombardi Comprehensive Cancer Center
panelists

KASEY ESTENSON
Eisai
Medical Director, HCC/GI, RCC, US Medical Affairs

JOSE RICARDO PEREZ, MD
Exelixis
VP, GU Portfolio, Medical Affairs

DANA WALKER
Bristol Myers Squibb
Vice President, Global Progam Lead, Opdivo Genitourinary Cancers and Gastrointestinal Cancers

CARMEN WHITE, MBA
Pfizer
Director of Multicultural Participant Experience

CHANA WEINSTOCK, MD
U.S. Food & Drug Administration (FDA)
GU Oncology Team Leader
FEATURED SPEAKER

WILLIAM G. KAELIN, Jr., MD
Sidney Farber Professor of Medicine, Harvard Medical School
Investigator, Howard Hughes Medical Institute
session 5
Clinical and Scientific Updates in Kidney Cancer

TONI CHOUEIRI, MD
Dana-Farber Cancer Institute
Director, Lank Center for Genitourinary Oncology

DAVID BRAUN, MD, PhD
Yale School of Medicine
Assistant Professor of Medicine

RAQUIBUL HANNAN, MD, PhD
UT Southwestern Medical Center
Chief of Genitourinary Radiation

CHUNG-HAN LEE, MD, PhD
Memorial Sloan Kettering Cancer Center
Assistant Attending Physician

BRADLEY MCGREGOR, MD
Dana-Farber Cancer Institute
Director of Clinical Research, Lank Center for Genitourinary Oncology

RANA MCKAY, MD
Associate Professor of Medicine

ROBERT MOTZER, MD
Memorial Sloan Kettering Cancer Center
Jack and Dorothy Byrne Chair in Clinical Oncology

THOMAS POWLES, MBBS, MRCP, MD
Barts Cancer Centre
Lead for Solid Tumour Research
session 6
Immunotherapy Advances and Research

HANS HAMMERS, MD, PhD
Professor of Internal Medicine, Division of Hematology-Oncology

DAVID BRAUN, MD, PhD
Assistant Professor of Medicine

MARICE ALCANTARA, PhD
Postdoctoral Fellow

MATTHEW DALLOS, MD, PhD
Memorial Sloan Kettering Cancer Center
Assistant Attending

QINQIN JIANG, PhD
Dana-Farber Cancer Institute
Postdoctoral Fellow

AVERY POSEY, PhD
Penn Medicine
Assistant Professor

JOHN WILSON, PhD
Vanderbilt University
Assistant Professor
session 7
Oral Abstract Presentations
MODERATORS

RANA MCKAY, MD
Associate Professor of Medicine

JOSHUA LANG, MD, MS
University of Wisconsin School of Medicine
Associate Professor
SPEAKERS

YASSER GED, MBBS
Johns Hopkins University
Assistant Professor of Oncology

CHUNG-HAN LEE, MD, PhD
Memorial Sloan Kettering Cancer Center
Assistant Attending Physician

ANUPAMA REDDY, PhD
Vindhya Data Science Inc.
Co-founder and Data Scientist

ED REZNIK, PhD
Memorial Sloan Kettering Cancer Center
Assistant Member

EDDY SAAD, MD
Dana-Farber Cancer Institute
Postdoctoral Research Fellow

WENXIN (Vincent) XU, MD
Dana-Farber Cancer Institute
Instructor of Medicine
session 8
Rapid Abstract Presentations
MODERATORS

DEEPAK KILARI, MD
Medical College of Wisconsin
Associate Professor

SUMANTA PAL, MD
City of Hope Comprehensive Cancer Center
Professor, Department of Medical Oncology & Therapeutics Research
SPEAKERS

DANIELA CASTRO, MS
City of Hope Comprehensive Cancer Center
Clinical Research Associate

GEORGE GEBRAEL, MD
Huntsman Cancer Institute
Postdoctoral Research Fellow

CHINMAY JANI, MB, BS
University of Miami, Sylvester Comprehensive Cancer Center
Hematology and Oncology Clinical Fellow

MEI KOH, PhD
Kuda Therapeutics, Inc
CEO

PRATHYUSHA KONDA
Dana-Farber Cancer Institute

CHRIS LABAKI, MD
Dana-Farber Cancer Institute
Medical Oncology Fellow

DAVID SCHOENFELD, MD, PhD
Yale University
Medical Oncology Fellow

KARL SEMAAN, MD
Dana-Farber Cancer Institute
Postdoctoral Research Fellow
Special Session for Investigators:
Expert Insights on the Research Funding Landscape

TAWNYA McKEE, PhD
National Cancer Institute
Program Director

DONALD BOTTARO, PhD
National Cancer Institute
Center for Cancer Research

DARSHAK SANGHAVI, MD
ARPA-H
Program Manager
Pre-meeting: Kidney Cancer Biomarkers Symposium
Session 1: Biomarker Technologies in RCC
moderators

TONI CHOUEIRI, MD
Dana-Farber Cancer Institute
Director, Lank Center for Genitourinary Oncology

MAHRUKH HUSENI
Genentech
Principal Scientist
speakers
ARI HAKIMI, MD, PhD
Memorial Sloan Kettering Cancer Center
Associate Professor
SABINA SIGNORETTI, MD
Brigham and Women’s Hospital
Associate Pathologist
DAVID BRAUN, MD, PhD
Yale School of Medicine
Assistant Professor of Medicine
TIM SHOWALTER, MD, MPH
Artera
VP of Clinical Development
HEATHER JACENE, MD
Dana-Farber Cancer Institute
Clinical Director, Nuclear Medicine
HEDYEH EBRAHIMI, MD, MPH
City of Hope Comprehensive Cancer C enter
Postdoctoral Fellow
RENEE MARIA SALIBY, MD
Dana-Farber Cancer Institute
Postdoctoral Research Fellow
Session 2: Clinical Biomarkers: Trial Data and Directions
moderators

THOMAS POWLES, MBBS, MRCP, MD
Director, Barts Cancer Centre

MEDHI MOLLAPOUR, PhD
State University of New York
Professor
speakers
THOMAS POWLES, MBBS, MRCP, MD
Barts Cancer Centre
Director, Barts Cancer Centre
DAVID McDERMOTT, MD
Beth Israel Deaconess Medical Center
Chief, Division of Medical Oncology
SAURABH GUPTA, PhD
Bristol Myers Squibb
Senior Director, Clinical Biomarkers Oncology, Precision Medicine
AXEL BEX, MD, PhD
Royal Free Hospital London
Clinical Lead of the Specialist Centre for Kidney Cancer
SYLVAN BACA, MD, PhD
Dana-Farber Cancer Institute
Assistant Professor of Medicine
ALEXANDER GUSEV, PhD
Dana-Farber Cancer Institute
Associate Professor
WENXIN (Vincent) XU, MD
Dana-Farber Cancer Institute
Instructor of Medicine
ADAM EINAGGAR, MD
Natera
Medical Director, Oncology